EquitiesIndia.com

Healthcare · Biotechnology

Blue Jet Healthcare Ltd.

BLUEJET

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

Key metrics

Market Cap

₹7,057 cr

P/E Ratio

24.05x

P/B Ratio

6.23x

ROE

26.93%

ROCE

35.23%

Debt / Equity

0.02x

Net Margin

29.74%

Dividend Yield

29%

EPS

₹17.59

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 79.81%FII: 1.86%Public: 18.33%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Blue Jet Healthcare Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.